Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Asian Cardiovasc Thorac Ann ; 26(4): 302-304, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29667898

RESUMO

A 76-year-old woman who had been on hemodialysis for 3 years developed ischemic mitral valve insufficiency, tricuspid insufficiency, and chronic atrial fibrillation, and underwent cardiac surgery. On the 4th postoperative day, she experienced a sudden disturbance of consciousness, aphasia, and limb ataxia. Brain computed tomography and magnetic resonance imaging showed no abnormalities. Wernicke's encephalopathy was suspected and the patient was given vitamin B1, whereupon her symptoms gradually improved. On the 42nd postoperative day, she was free of neurological symptoms and discharged.


Assuntos
Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Encefalopatia de Wernicke/etiologia , Idoso , Ponte Cardiopulmonar/efeitos adversos , Diagnóstico Precoce , Feminino , Humanos , Valor Preditivo dos Testes , Diálise Renal/efeitos adversos , Fatores de Risco , Tiamina/administração & dosagem , Fatores de Tempo , Resultado do Tratamento , Vitaminas/administração & dosagem , Encefalopatia de Wernicke/diagnóstico , Encefalopatia de Wernicke/tratamento farmacológico
2.
Ann Thorac Cardiovasc Surg ; 24(4): 187-192, 2018 Aug 20.
Artigo em Inglês | MEDLINE | ID: mdl-29681597

RESUMO

Antithrombin III (ATIII) deficiency is a rare disorder in which thrombosis can be induced by stimuli that do not usually lead to thrombus formation, including minor injuries and surgery. Therefore, patients with ATIII deficiency undergoing cardiovascular surgery that involves heparinization require careful perioperative management. We experienced five patients with ATIII deficiency who underwent cardiovascular surgery and were managed with ATIII replacement. By administration of ATIII concentrate, preoperative ATIII activity was maintained at ≥120% and postoperative ATIII activity at ≥80%. All five patients were treated successfully without postoperative complications such as hemorrhage or thrombosis. In patients with ATIII deficiency undergoing cardiac surgery, it is important to perform ATIII replacement to achieve preoperative ATIII activity ≥120% and postoperative ATIII activity ≥80%, while the activated clotting time (ACT) is maintained at >400 seconds during cardiopulmonary bypass. In addition, long-term postoperative anticoagulant therapy is necessary in hereditary ATIII deficiency patients with a history of thrombosis.


Assuntos
Deficiência de Antitrombina III/tratamento farmacológico , Antitrombina III/administração & dosagem , Antitrombinas/administração & dosagem , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Trombose/prevenção & controle , Procedimentos Cirúrgicos Vasculares/efeitos adversos , Idoso , Idoso de 80 Anos ou mais , Antitrombina III/efeitos adversos , Deficiência de Antitrombina III/sangue , Deficiência de Antitrombina III/complicações , Deficiência de Antitrombina III/diagnóstico , Antitrombinas/efeitos adversos , Testes de Coagulação Sanguínea , Tomada de Decisão Clínica , Monitoramento de Medicamentos/métodos , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Intraoperatória/métodos , Hemorragia Pós-Operatória/induzido quimicamente , Fatores de Risco , Trombose/sangue , Trombose/etiologia , Resultado do Tratamento
3.
Yakugaku Zasshi ; 138(1): 91-96, 2018.
Artigo em Japonês | MEDLINE | ID: mdl-29311469

RESUMO

This study investigated the sex differences of the inflammatory mediator level at the time of itch onset in patients with chronic venous disease (CVD). Twenty-seven CVD patients (nineteen women, eight men) and nine healthy controls (five women, four men) participated. CVD-associated itching was observed in both men and women. Before sclerotherapy, both sexes had elevations in several itch-related mediators. Among these, women had significantly higher tryptase, whereas men had significantly higher ß-endorphin and adrenocorticotropic hormone. After sclerotherapy, all levels normalized in both sexes. In this study, itching was increased tryptase in women and increased adrenocorticotropic hormone and ß-endorphin in men.


Assuntos
Hormônio Adrenocorticotrópico/metabolismo , Mediadores da Inflamação/metabolismo , Prurido/fisiopatologia , Caracteres Sexuais , Triptases/metabolismo , Doenças Vasculares/metabolismo , Doenças Vasculares/fisiopatologia , beta-Endorfina/metabolismo , Adulto , Idoso , Doença Crônica , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Escleroterapia , Doenças Vasculares/terapia
4.
Artigo em Inglês | MEDLINE | ID: mdl-28944076

RESUMO

BACKGROUND: Varicose veins commonly occur in the lower extremities and can cause pain and discomfort in the affected area. Many patients with varicose veins suffer from itching, but its cause has not been sufficiently explained. In recent years, the role of zinc in maintaining the integrity of skin has been reported, and zinc supplementation has been suggested to be effective in relieving itching. The objective of this study is to elucidate the relationship between itching and serum zinc concentration in patients with varicose veins. METHODS: We measured the stratum corneum water content, TEWL and zinc levels in each participant. The study subjects were 11 patients with varicose veins who were experiencing itching (2 males and 9 females, mean age: 65.9 ± 9.4 years old) and 13 patients without itching (6 males and 7 females, mean age: 59.3 ± 9.5 years old). The control group was comprised of 9 healthy individuals without varicose veins (mean age: 41.7 ± 7.0 years old). RESULTS: The level of stratum corneum water content was significantly lower in the patients experiencing itching compared to those without the symptom, and it was significantly lower in both patient groups than in the control group. Transepidermal water loss (TEWL) was significantly higher in the patients experiencing itching than those without the symptom, and it was significantly higher in both patient groups than in the control group. In addition, zinc level was significantly lower in the patients with itching compared to those without itching or the control group. For all study participants, relationships between the stratum corneum water content and TEWL against serum zinc were examined. There was a positive correlation between the stratum corneum water content and serum zinc, and a negative correlation was found between TEWL and serum zinc. CONCLUSION: Our novel findings suggested that the development of varicose veins leads to decrease in serum zinc, causing dry skin which could contribute to itching.

5.
Arch Dermatol Res ; 309(4): 253-258, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-28251309

RESUMO

Chronic venous disease (CVD) is a common venous disease of the lower extremities and patients often develop symptoms of itching and skin roughness. An easy to use and objective skin examination was recently developed that allows measurement of the level of stratum corneum content and transepidermal water loss (TEWL), which can indicate the status of the barrier function of the stratum corneum. Previous studies demonstrated that histamine production from mast cells, and tryptase and matrix metalloprotease-9 levels were associated with skin inflammation. This study aimed to clarify the relationship between dry skin and inflammatory mediators that mediate the skin symptoms of CVD subjects. The study enrolled 27 subjects with CVD and a control group consisting of 9 volunteers. The itching onset frequency was higher in women (70.4%) compared with men (50.0%). To analyze the mechanisms involved in itching we measured blood inflammatory mediators pre- and post-sclerotherapy. There was a significant decrease in Substance P, histamine, IgE, and tryptase levels post-sclerotherapy compared with those at pre-sclerotherapy. These levels were associated with the severity of itching. In addition, compared with the control subjects, there was a significant increase in the stratum corneum water content and a decrease in the TEWL in the 27 patients with CVD. This was associated with a decrease in the itching symptoms. Our findings indicate that sclerotherapy decreased levels of inflammatory mediators, increased stratum corneum water content and decreased TEWL, which coincided with reduced itching in CVD patients, indicating they might be therapeutic targets.


Assuntos
Epiderme/metabolismo , Inflamação/fisiopatologia , Pele/metabolismo , Varizes/fisiopatologia , Água/metabolismo , Adulto , Idoso , Doença Crônica , Epiderme/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pele/patologia
6.
Cardiovasc Interv Ther ; 30(1): 72-7, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24566833

RESUMO

Although percutaneous transluminal septal myocardial ablation (PTSMA) has been the established treatment of symptomatic patients with hypertrophic obstructive cardiomyopathy (HOCM), the efficacy for specific HOCM is not elucidated. We report a successful case of PTSMA for heart failure with severe left ventricular outflow tract (LVOT) obstruction due to sigmoid-shaped interventricular septum and diffuse left ventricular hypertrophy with Mönckeberg's arteriosclerosis and aortic valvular stenosis. While the PTSMA relieved LVOT obstruction and symptoms in the acute phase, the modest recurrence was confirmed 6 months later, which is rare in the case of idiopathic HOCM. The possible mechanisms of LVOT obstruction and recurrence are discussed.


Assuntos
Técnicas de Ablação/métodos , Estenose da Valva Aórtica/cirurgia , Cardiomiopatia Hipertrófica/complicações , Insuficiência Cardíaca/cirurgia , Esclerose Calcificante da Média de Monckeberg/complicações , Obstrução do Fluxo Ventricular Externo/complicações , Cardiomiopatia Hipertrófica/cirurgia , Angiografia Coronária , Ecocardiografia , Feminino , Insuficiência Cardíaca/etiologia , Humanos , Pessoa de Meia-Idade , Tomografia Computadorizada por Raios X , Obstrução do Fluxo Ventricular Externo/cirurgia
8.
Jpn J Thorac Cardiovasc Surg ; 54(11): 486-9, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17144599

RESUMO

An 88-year-old woman developed an acute massive pulmonary embolism after off-pump coronary artery bypass surgery. She experienced dyspnea while walking on the sixth day after operation. Her chest radiograph showed pleural effusion. Initially, she was treated for heart failure due to bypass graft occlusion. A repeat echocardiogram revealed enlargement of the right ventricle. Multislice computed tomography showed a massive embolus in the pulmonary artery. Surgical embolectomy was performed, and her postoperative course was easy. Recently, the incidence of pulmonary embolism in Japanese people has been rising. In addition, widespread implementation of off-pump coronary artery bypass compromises the protective effect against pulmonary embolus after cardiac surgery. Although the incidence of pulmonary embolism after coronary artery bypass surgery is still low in Japan in comparison to that in Western countries, prophylaxis against pulmonary embolism after off-pump coronary artery surgery is becoming more important.


Assuntos
Ponte de Artéria Coronária sem Circulação Extracorpórea/efeitos adversos , Anastomose de Artéria Torácica Interna-Coronária/efeitos adversos , Embolia Pulmonar/etiologia , Doença Aguda , Idoso de 80 Anos ou mais , Estenose Coronária/cirurgia , Embolectomia , Feminino , Humanos , Balão Intra-Aórtico/efeitos adversos , Embolia Pulmonar/cirurgia , Reoperação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...